tiprankstipranks
Zenas BioPharma, Inc. (ZBIO)
NASDAQ:ZBIO
US Market
ZBIO
Zenas BioPharma, Inc.
RESEARCH TOOLSreports

Zenas BioPharma, Inc. (ZBIO) Financial Statements

Compare
237 Followers

Zenas BioPharma, Inc. Financial Overview

Zenas BioPharma, Inc.'s market cap is currently $1.27B. The company's EPS TTM is $-4.54; its P/E ratio is -4.30; Zenas BioPharma, Inc. is scheduled to report earnings on March 16, 2026, and the estimated EPS forecast is $-1.47. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22
Income Statement
Total Revenue$ 10.00M$ 5.00M$ 50.00M$ 0.00
Gross Profit$ 9.94M$ -134.14M$ 50.00M$ -61.69M
Operating Income$ -211.38M$ -163.89M$ -37.15M$ -76.20M
EBITDA$ -211.33M$ -163.75M$ -27.03M$ -75.12M
Net Income$ -377.74M$ -156.99M$ -37.12M$ -119.28M
Balance Sheet
Cash & Short-Term Investments$ 343.19M$ 350.77M$ 56.86M$ 67.21M
Total Assets$ 383.64M$ 369.97M$ 68.18M$ 74.58M
Total Debt$ 79.96M$ 1.00M$ 21.11M$ 1.53M
Net Debt$ -30.68M$ -318.74M$ -35.74M$ -65.68M
Total Liabilities$ 141.50M$ 57.51M$ 293.90M$ 266.87M
Stockholders' Equity$ 242.14M$ 312.46M$ -225.72M$ -192.29M
Cash Flow
Free Cash Flow$ -172.35M$ -119.81M$ -30.55M$ -67.85M
Operating Cash Flow$ -172.33M$ -119.67M$ -30.53M$ -65.65M
Investing Cash Flow$ -251.89M$ -30.55M$ -17.00K$ -2.20M
Financing Cash Flow$ 215.28M$ 412.96M$ 20.12M$ 59.39M
Currency in USD

Zenas BioPharma, Inc. Earnings and Revenue History

Income Statement >

Zenas BioPharma, Inc. Debt to Assets

Balance Sheet >

Zenas BioPharma, Inc. Cash Flow

Cash Flow >

Zenas BioPharma, Inc. Forecast EPS vs Actual EPS

Earnings >